PlainRecalls
FDA Drug Low Class III Terminated

Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA

Reported: November 30, 2016 Initiated: November 3, 2016 #D-0151-2017

Product Description

Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA

Reason for Recall

Failed Impurities/Degradation Specifications: OOS results for known compound.

Details

Units Affected
51,983 extended release capsules
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC 0378-5220-05), Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 51,983 extended release capsules.
Why was this product recalled?
Failed Impurities/Degradation Specifications: OOS results for known compound.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 30, 2016. Severity: Low. Recall number: D-0151-2017.